The global mRNA vaccine patent landscape

In light of their quick development and low risk, mRNA vaccines are gradually replacing traditional vaccines. In order to characterize the patent landscape of mRNA vaccines, this study collated mRNA vaccine–related applications that have been registered since 1962. Accordingly, the 1852 patent famil...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengyao, Ren, Jianxiong, Si, Xingyong, Sun, Zhaocai, Wang, Pingping, Zhang, Xiaoming, Liu, Kunmeng, Wei, Benzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Technology – Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746484/
https://www.ncbi.nlm.nih.gov/pubmed/35797353
http://dx.doi.org/10.1080/21645515.2022.2095837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746484/
https://www.ncbi.nlm.nih.gov/pubmed/35797353
http://dx.doi.org/10.1080/21645515.2022.2095837

Ejemplares similares